Graduate School of Environmental Studies, Tohoku University, 6-6-20 Aoba, Aramaki, Sendai 980-8579, Japan.
Mater Sci Eng C Mater Biol Appl. 2013 May 1;33(4):2446-50. doi: 10.1016/j.msec.2013.01.017. Epub 2013 Jan 17.
Spherical Ca-deficient hydroxyapatite (HA) granules are expected to be useful drug carriers in bony sites because of their bone regeneration and adsorption ability. In order to control drug loading and release ability of the granules, a controlled surface microstructure was constructed. Spherical Ca-deficient granules composed of micron-sized rod-shaped particles were prepared by hydrothermal treatment of α-tricalcium phosphate (α-TCP) granules, and then, submicron HA particles were precipitated on the obtained granules by immersion in a supersaturated calcium phosphate (CP) solution. When bovine serum albumin was used as a drug model, precipitation of submicron particles causes the loading capability to increase and the release rate to decrease. The spherical Ca-deficient HA granules with the controlled surface microstructure are expected to be useful drug carriers that can act as scaffolds for bone repair.
球形缺钙羟基磷灰石(HA)颗粒由于其具有骨再生和吸附能力,有望成为骨内药物载体。为了控制颗粒的药物负载和释放能力,构建了控制表面微观结构。通过对α-磷酸三钙(α-TCP)颗粒进行水热处理,制备了由微米级棒状颗粒组成的球形缺钙颗粒,然后将亚微米 HA 颗粒通过浸泡在过饱和的磷酸钙(CP)溶液中沉淀在获得的颗粒上。当牛血清白蛋白用作药物模型时,亚微米颗粒的沉淀会导致负载能力增加和释放速率降低。具有控制表面微观结构的球形缺钙 HA 颗粒有望成为有用的药物载体,可作为骨修复的支架。